Today: 2 May 2026
Netflix stock ticks up as Warner Bros deal fight stays in focus
29 December 2025
2 mins read

Netflix stock ticks up as Warner Bros deal fight stays in focus

NEW YORK, December 29, 2025, 10:05 ET — Regular session

  • Netflix shares up about 0.2% in early New York trading, despite a softer open for U.S. stocks.
  • Investors remain focused on the regulatory path and financing for Netflix’s proposed Warner Bros Discovery deal.
  • Netflix’s next scheduled catalyst is its fourth-quarter results on Jan. 20, the company said.

Netflix (NFLX.O) shares edged higher on Monday, trading up 0.2% at $94.63 by 10:05 a.m. ET.

The stock’s muted move comes as investors head into the final stretch of the year with a single question dominating the narrative: whether Netflix can land a transformative Warner Bros Discovery deal without a long regulatory fight, while keeping growth and margins on track.

With Netflix set to report results next month, traders are positioning for fresh guidance and any update on the transaction’s timeline and financing, after weeks of headline-driven swings across the media sector.

Wall Street opened lower on Monday as heavyweight technology stocks gave up some ground after last week’s gains, Reuters reported. The Dow was down 0.15% at the open, the S&P 500 slipped 0.38% and the Nasdaq dropped 0.76%.

Entertainment and streaming peers were mixed. Walt Disney rose about 0.4%, while Warner Bros Discovery added about 0.8% and Roku fell about 1.2%.

Netflix agreed on Dec. 5 to buy Warner Bros Discovery’s TV and film studios and streaming division for $72 billion, Reuters reported. The deal is expected to close after Warner Bros completes a planned spinoff of its global networks unit in the third quarter of 2026.

The proposed acquisition has also become a competitive flashpoint. Paramount Skydance has pursued Warner Bros with a $30-per-share all-cash bid and, in a bid to bolster its financing, Oracle co-founder Larry Ellison offered a personal guarantee of $40.4 billion, Reuters reported.

“I doubt many Warner Bros shareholders that are on the fence or planning to vote no were holding out,” said Seth Shafer, a principal analyst at S&P Global, in comments cited by Reuters. Reuters

Both potential combinations face antitrust scrutiny in the United States and Europe, Reuters has reported, a key overhang for Netflix investors because a tie-up would further expand the market leader’s position in streaming.

An SEC filing on Dec. 19 showed Netflix replaced part of its bridge financing — short-term funding companies use while lining up longer-term debt — with a $5 billion revolving credit facility and up to $20 billion in delayed-draw term loans. The facilities can be used to fund the cash portion of the purchase price and related costs, the filing said.

Next up, Netflix said it will post fourth-quarter results and its business outlook on Jan. 20, 2026, at about 1:01 p.m. Pacific time, followed by a live video interview with executives at 1:45 p.m., according to a company release.

That report is expected to sharpen investors’ focus on advertising momentum, content spending and cash generation, as well as any detail on how management plans to integrate Warner Bros assets if the deal clears regulators. Reuters has reported Netflix stopped disclosing subscriber figures earlier this year, pushing Wall Street to weigh performance through revenue and profitability instead.

For now, Netflix shares are holding near $95 in early trade, with the next decisive catalyst seen as January’s earnings and any sign of regulatory feedback on the proposed deal.

Stock Market Today

  • Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
    May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026
LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:37 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could
US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

Nike stock slips as UBS flags better brand signals but keeps neutral stance
Next Story

Nike stock slips as UBS flags better brand signals but keeps neutral stance

Go toTop